Should Low-Risk Pregnant Patients be Screened for Asymptomatic Bacteriuria?

Area of Science:

• Obstetrics and Gynecology
• Infectious Diseases
• Clinical Trials

Background:

• Asymptomatic bacteriuria (ASB) is the presence of bacteria in urine without symptoms.
• Routine screening and treatment for ASB are generally not recommended due to limited benefits and potential harms.
• Pregnancy is a recognized exception where ASB screening is standard practice.

Purpose of the Study:

• To review the existing evidence regarding the screening and treatment of asymptomatic bacteriuria.
• To propose a clinical trial addressing the specific question of whether low-risk pregnant patients should be screened for ASB.
• To evaluate the clinical utility and potential impact of ASB screening in a low-risk obstetric population.

Main Methods:

• Literature review of current guidelines and research on ASB screening and treatment.
• Analysis of the benefits and risks associated with ASB in pregnant populations.
• Proposal of a prospective clinical trial design for low-risk pregnant patients.

Main Results:

• General consensus against ASB screening in non-pregnant individuals due to lack of proven benefit and risk of harm.
• Established recommendation for ASB screening in all pregnant women.
• Identification of a knowledge gap regarding the necessity of ASB screening in *low-risk* pregnant populations.

Conclusions:

• The current evidence supports ASB screening in pregnancy but requires further investigation for specific low-risk subgroups.
• A well-designed trial is needed to determine the optimal screening strategy for asymptomatic bacteriuria in low-risk pregnant patients.
• Future research should focus on refining screening protocols to maximize benefits and minimize harms in obstetric care.